Found: 6
Select item for more details and to access through your institution.
The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. 1, doi. 10.3389/fphar.2021.656561
- By:
- Publication type:
- Article
The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pharmacokinetics, mass balance, tissue distribution, metabolism, and excretion of praliciguat, a clinical‐stage soluble guanylate cyclase stimulator in rats.
- Published in:
- Pharmacology Research & Perspectives, 2020, v. 8, n. 2, p. 1, doi. 10.1002/prp2.579
- By:
- Publication type:
- Article
Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 2, p. 150, doi. 10.1038/nbt781
- By:
- Publication type:
- Article
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease.
- Published in:
- Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00419
- By:
- Publication type:
- Article
Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141330
- By:
- Publication type:
- Article